0001209191-17-065674.txt : 20171214
0001209191-17-065674.hdr.sgml : 20171214
20171214161353
ACCESSION NUMBER: 0001209191-17-065674
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171213
FILED AS OF DATE: 20171214
DATE AS OF CHANGE: 20171214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Williams Anthony L
CENTRAL INDEX KEY: 0001635534
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35621
FILM NUMBER: 171256335
MAIL ADDRESS:
STREET 1: C/O GLOBUS MEDICAL, INC.
STREET 2: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLOBUS MEDICAL INC
CENTRAL INDEX KEY: 0001237831
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043744954
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
BUSINESS PHONE: 610-930-1800
MAIL ADDRESS:
STREET 1: 2560 GENERAL ARMISTEAD AVENUE
CITY: AUDUBON
STATE: PA
ZIP: 19403
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-12-13
0
0001237831
GLOBUS MEDICAL INC
GMED
0001635534
Williams Anthony L
2560 GENERAL ARMISTEAD AVENUE
AUDUBON
PA
19403
0
1
0
0
President
Class A Common Stock
2017-12-13
4
M
0
15000
13.04
A
15000
D
Class A Common Stock
2017-12-13
4
S
0
15000
38.2994
D
0
D
Stock Option (Right to Buy Class A Common Stock)
13.04
2017-12-13
4
M
0
15000
0.00
D
2023-01-24
Class A Common Stock
15000
10000
D
This sale was pursuant to a Rule 10b5-1 Plan entered into by the reporting person on November 13, 2017, which is intended to comply with Rule 10b5-1.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.01 to $38.60, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
These options were granted on January 24, 2013, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
/s/ Anthony L. Williams
2017-12-14